Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,2.5206164054382494e-49,31.985174203113417,3579.2102757669577,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",1.1796484777451007e-46,0,0,67
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,5.2110502630121045e-15,6.653446284174047,218.81850795017087,"['NDUFB9', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX4I1', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'ATP5MC1', 'ATP5IF1', 'UQCRFS1', 'ATP5MF', 'ATP5PF', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA4', 'NDUFA1', 'NDUFC1', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'SLC25A5']",1.2193857615448325e-12,0,0,37
3,Nonalcoholic fatty liver disease WP4396,2.7323613368772017e-10,3.975904353157572,87.5521363015383,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'BBC3', 'LEPR', 'MLX', 'UQCRFS1', 'CYC1', 'XBP1', 'JUN', 'NDUFA7', 'TGFB1', 'NDUFA6', 'NDUFA4', 'NDUFA1', 'NDUFC1', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",4.2624836855284345e-08,0,0,38
4,Oxidative phosphorylation WP623,7.132846223971301e-09,6.306493961141257,118.3007169317812,"['NDUFB9', 'ATP5PF', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'ATP5PD', 'ATP6AP1', 'NDUFB10', 'NDUFB5', 'NDUFA4', 'ATP6AP2', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'ATP5MF']",8.345430082046423e-07,0,0,21
5,Mitochondrial CIV Assembly WP4922,2.89708856821091e-07,8.091505466778806,121.81267380747502,"['COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX5B', 'COX7C', 'PET117', 'COX6B1', 'COX14', 'COX20']",2.711674899845412e-05,0,0,14
6,Cholesterol Biosynthesis Pathway WP197,3.984814919180342e-06,12.96105527638191,161.1450554696247,"['IDI1', 'SQLE', 'HMGCS1', 'CYP51A1', 'MSMO1', 'HMGCR', 'DHCR7', 'LSS', 'FDFT1']",0.00031081556369606664,0,0,9
7,Mitochondrial complex I assembly model OXPHOS system WP4324,2.1293888686731206e-05,4.203109443210538,45.21322842048071,"['NDUFB9', 'NDUFA13', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4']",0.0014236485579128865,0,0,16
8,"GPCRs, Class A Rhodopsin-like WP455",0.0001151461814073195,3.7113997113997113,33.65982744321054,"['GPR27', 'P2RY12', 'GPR12', 'HTR1F', 'P2RY14', 'CHRM5', 'F2R', 'OPRK1', 'ADRA1D', 'NMBR', 'HTR4', 'MCHR1', 'HCRTR2', 'HRH1', 'HTR7']",0.006736051612328191,0,0,15
9,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.0002303057617139152,3.8777745580991017,32.48063807464537,"['IDI1', 'HMGCS1', 'CYP51A1', 'MSMO1', 'DHCR24', 'HMGCR', 'LSS', 'SQLE', 'EBP', 'SCD', 'ACOT2', 'DHCR7', 'FDFT1']",0.01197589960912359,0,0,13
10,Mitochondrial complex III assembly WP4921,0.0004007070499646101,7.546509197324415,59.03090755921538,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1']",0.018753089938343754,0,0,7
11,Selenium Micronutrient Network WP15,0.0010087673708014048,3.654717346411977,25.213990428276997,"['SELENOM', 'GPX4', 'RFK', 'SELENOW', 'PNPO', 'PLAT', 'KMO', 'SELENOK', 'SEPHS2', 'LDLR', 'SELENOH']",0.04291846632136886,0,0,11
12,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.0031890552759272594,11.476230191826522,65.96572183089594,"['EBP', 'CYP51A1', 'DHCR24', 'DHCR7']",0.12437315576116312,0,0,4
13,Monoamine GPCRs WP58,0.00573400296582156,4.699020277967646,24.253247873267377,"['HRH1', 'HTR7', 'HTR1F', 'CHRM5', 'ADRA1D', 'HTR4']",0.19566358210110235,0,0,6
14,miR-509-3p alteration of YAP1/ECM axis WP3967,0.005853184079947506,8.606338615512927,44.243202877455865,"['COL5A1', 'PBX3', 'FN1', 'GPC6']",0.19566358210110235,0,0,4
15,Allograft Rejection WP2328,0.009312634512837049,3.548199881959473,16.59274249937032,"['ABCB1', 'TGFB1', 'COL5A1', 'HLA-B', 'HLA-C', 'HLA-A', 'HLA-F']",0.27068194460968104,0,0,7
16,Senescence and Autophagy in Cancer WP615,0.010823468017224946,2.1982108723908556,9.94918712257957,"['GABARAPL1', 'JUN', 'TGFB1', 'CDKN1B', 'IGFBP5', 'FN1', 'PLAT', 'IGF1', 'CXCL14', 'GABARAP', 'MAP1LC3A', 'IGFBP7', 'HRAS', 'SLC39A3']",0.27068194460968104,0,0,14
17,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.010885448167481392,inf,inf,"['TGFB1', 'VIP']",0.27068194460968104,0,0,2
18,Gastric acid production WP2596,0.010885448167481392,inf,inf,"['CCK', 'VIP']",0.27068194460968104,0,0,2
19,Imatinib and Chronic Myeloid Leukemia WP3640,0.01098922424697423,4.782971619365609,21.575220178898796,"['SPRED2', 'ABCB1', 'CDKN1B', 'GADD45A', 'KIT']",0.27068194460968104,0,0,5
20,Cardiac Progenitor Differentiation WP2406,0.013678970775882177,3.691013247404225,15.841443535635342,"['MESP1', 'TGFB1', 'TNNT2', 'KIT', 'THY1', 'IGF1']",0.3200879161556429,0,0,6
21,Cellular Proteostasis WP4918,0.017802488170323042,8.6,34.64438660078993,"['VBP1', 'PFDN5', 'PFDN6']",0.3856165503859297,0,0,3
22,Proximal tubule transport WP4917,0.018127273736090712,3.015091973244147,12.091536824144239,"['ATP6V1G1', 'ABCB1', 'SLC3A1', 'ATP1A1', 'ATP6V0C', 'ATP6V1D', 'ATP6V1F']",0.3856165503859297,0,0,7
23,TP53 network WP1742,0.021372133867824848,4.916478017395448,18.907139043579043,"['SUMO1', 'GADD45A', 'BAX', 'BBC3']",0.4287826356360369,0,0,4
24,Photodynamic therapy-induced unfolded protein response WP3613,0.021988853109540355,3.2290100250626566,12.325840455935452,"['XBP1', 'HSPA5', 'DDIT3', 'DNAJB9', 'CALR', 'BBC3']",0.4287826356360369,0,0,6
25,Mevalonate pathway WP3963,0.02876258845830419,6.449375,22.88676645073757,"['HMGCS1', 'HMGCR', 'ACAT2']",0.49039199241877957,0,0,3
26,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.029462895604627247,4.301501251042535,15.161172753513492,"['CD81', 'HSPB1', 'IGF1', 'PDLIM5']",0.49039199241877957,0,0,4
27,miRNA targets in ECM and membrane receptors WP2911,0.029462895604627247,4.301501251042535,15.161172753513492,"['COL5A1', 'ITGA1', 'COL5A2', 'FN1']",0.49039199241877957,0,0,4
28,Statin inhibition of cholesterol production WP430,0.029462895604627247,4.301501251042535,15.161172753513492,"['SQLE', 'HMGCR', 'LDLR', 'FDFT1']",0.49039199241877957,0,0,4
29,miR-517 relationship with ARCN1 and USP1 WP3596,0.030387537991761984,17.18900915903414,60.05363130202375,"['ID2', 'ARCN1']",0.49039199241877957,0,0,2
30,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.039127219270733364,3.823185988323603,12.390704580125373,"['OMG', 'IGF1', 'ASCL1', 'SOX6']",0.6103846206234405,0,0,4
31,Matrix Metalloproteinases WP129,0.04250825549171419,5.159,16.29241593429008,"['MMP16', 'TIMP2', 'TIMP3']",0.6417375345200723,0,0,3
32,Development of ureteric collection system WP5053,0.04745826953688559,2.5822055137844613,7.870315779943656,"['GDF11', 'FRAS1', 'ANOS1', 'ETV4', 'GLI3', 'FREM2']",0.6940771919769517,0,0,6
33,Folate Metabolism WP176,0.05035778687539576,2.8681135225375627,8.571649858016125,"['AHCY', 'GPX4', 'RFK', 'PLAT', 'LDLR']",0.7005236282642284,0,0,5
34,Glycolysis and Gluconeogenesis WP534,0.055838561751265246,2.459004654493376,7.094942959547749,"['LDHA', 'PKM', 'GOT1', 'PGAM1', 'ALDOC', 'PFKM']",0.7005236282642284,0,0,6
35,Apoptosis Modulation and Signaling WP1772,0.056136406228520855,1.9145012573344509,5.513707573241168,"['HRK', 'JUN', 'ENDOG', 'BAG3', 'PTRH2', 'CYCS', 'BAX', 'PRKD1', 'PTPN13', 'BBC3']",0.7005236282642284,0,0,10
36,ACE Inhibitor Pathway WP554,0.05659176877622377,8.593671940049958,24.680095394990825,"['TGFB1', 'ATP6AP2']",0.7005236282642284,0,0,2
37,Cytokines and Inflammatory Response WP530,0.05659176877622377,8.593671940049958,24.680095394990825,"['TGFB1', 'IL7']",0.7005236282642284,0,0,2
38,Alanine and aspartate metabolism WP106,0.05892637097864787,4.29875,12.171766891686804,"['GOT1', 'GAD1', 'GAD2']",0.7005236282642284,0,0,3
39,One-carbon metabolism WP241,0.06321529228872616,3.127454697096065,8.635556183390706,"['ALDH1L1', 'AHCY', 'CHDH', 'GLRX']",0.7005236282642284,0,0,4
40,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.06321529228872616,3.127454697096065,8.635556183390706,"['HMGCS1', 'SCD', 'HMGCR', 'LDLR']",0.7005236282642284,0,0,4
41,GABA receptor Signaling WP4159,0.0650528513600594,2.3470038733196628,6.413317736152433,"['GABBR1', 'SLC32A1', 'GAD1', 'GAD2', 'SLC6A1', 'GABRD']",0.7005236282642284,0,0,6
42,Endochondral Ossification with Skeletal Dysplasias WP4808,0.06586340109313132,2.0258921978833375,5.510775965298793,"['ADAMTS5', 'TGFB1', 'HMGCS1', 'TIMP3', 'PLAT', 'IGF1', 'SOX6', 'GLI3']",0.7005236282642284,0,0,8
43,Endochondral Ossification WP474,0.06586340109313132,2.0258921978833375,5.510775965298793,"['ADAMTS5', 'TGFB1', 'HMGCS1', 'TIMP3', 'PLAT', 'IGF1', 'SOX6', 'GLI3']",0.7005236282642284,0,0,8
44,IL-18 signaling pathway WP4754,0.07084498461977921,1.4606005340975705,3.8665909824897655,"['JUN', 'TOMM40', 'TICAM2', 'USP5', 'EPB41', 'CD81', 'RGS16', 'PRKCD', 'COX17', 'FN1', 'HSPB1', 'NDUFC1', 'CENPB', 'ADAMTS5', 'ARL4D', 'TMSB4X', 'RFX5', 'TIMP3', 'CYCS', 'BAX', 'ITM2C', 'ARF6']",0.7005236282642284,0,0,22
45,Aryl Hydrocarbon Receptor Pathway WP2873,0.07199051952207555,2.5301973878032014,6.657508101010634,"['JUN', 'CDKN1B', 'TGFB1', 'AIP', 'BAX']",0.7005236282642284,0,0,5
46,Oxysterols derived from cholesterol WP4545,0.07199051952207555,2.5301973878032014,6.657508101010634,"['EBP', 'DBP', 'INSIG1', 'ACOT2', 'DHCR7']",0.7005236282642284,0,0,5
47,Methionine De Novo and Salvage Pathway WP3580,0.07758551536152528,2.866555462885738,7.327989365347363,"['AHCY', 'CHDH', 'ODC1', 'SRM']",0.7005236282642284,0,0,4
48,Nucleotide metabolism WP404,0.07758551536152528,2.866555462885738,7.327989365347363,"['PRPS1', 'NME2', 'OAZ1', 'SRM']",0.7005236282642284,0,0,4
49,Computational Model of Aerobic Glycolysis WP4629,0.07783595869602539,3.684285714285714,9.40654055776182,"['LDHA', 'PKM', 'PFKM']",0.7005236282642284,0,0,3
50,Cysteine and methionine catabolism WP4504,0.07783595869602539,3.684285714285714,9.40654055776182,"['AHCY', 'GOT1', 'GSS']",0.7005236282642284,0,0,3
51,Glycolysis in senescence WP5049,0.07783595869602539,3.684285714285714,9.40654055776182,"['LDHA', 'PKM', 'ALDOC']",0.7005236282642284,0,0,3
52,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.07783595869602539,3.684285714285714,9.40654055776182,"['IDI1', 'HMGCS1', 'HMGCR']",0.7005236282642284,0,0,3
53,Pyrimidine metabolism WP4022,0.0856480715575069,1.6918893815915628,4.1578326544957145,"['NT5C', 'POLE4', 'POLE2', 'POLR1C', 'DPYD', 'POLE3', 'NME2', 'POLR2E', 'POLR2I', 'POLR2K', 'POLR2L']",0.7451726417968371,0,0,11
54,Ferroptosis WP4313,0.08598145866886582,2.151002506265664,5.277750519155688,"['MAP1LC3A', 'GPX4', 'GSS', 'SAT2', 'SLC7A11', 'FTL']",0.7451726417968371,0,0,6
55,Dopaminergic Neurogenesis WP2855,0.08788889116185729,5.728559533721898,13.930034317484909,"['TGFB1', 'ASCL1']",0.7478545647954402,0,0,2
56,Vitamin D Receptor Pathway WP2877,0.0907916425392725,1.7222129086336966,4.1319126129516155,"['ADAMTS5', 'SFRP1', 'ABCB1', 'TGFB1', 'CDKN1B', 'IGFBP5', 'GADD45A', 'PNOC', 'TIMP2', 'TIMP3']",0.7538798045231949,0,0,10
57,7-oxo-C and 7beta-HC pathways WP5064,0.09342954842381476,2.645794572400077,6.2719820252871585,"['EBP', 'DBP', 'ACOT2', 'DHCR7']",0.7538798045231949,0,0,4
58,Differentiation Pathway WP2848,0.09342954842381476,2.645794572400077,6.2719820252871585,"['TGFB1', 'KIT', 'IGF1', 'FGF1']",0.7538798045231949,0,0,4
59,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.09516689115291824,1.9431438127090301,4.570513603328892,"['BEX3', 'CDKN1B', 'HSPA5', 'F2R', 'HSPB1', 'PTK2B', 'RNF7']",0.754883136602809,0,0,7
60,NOTCH1 regulation of endothelial cell calcification WP3413,0.0990099102875575,3.2234375,7.454313102612776,"['ITGA1', 'PLAT', 'SOX6']",0.7722773002429485,0,0,3
61,Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) WP688,0.10437246838607372,inf,inf,['FMO5'],0.7810913737255099,0,0,1
62,Codeine and Morphine Metabolism WP1604,0.10437246838607372,inf,inf,['ABCB1'],0.7810913737255099,0,0,1
63,Proteasome Degradation WP183,0.10514691569381864,1.721608040201005,3.8777442851499515,"['PSMD8', 'PSMB6', 'PSMC5', 'H2AFZ', 'HLA-B', 'HLA-C', 'HLA-A', 'HLA-F', 'PSMB10']",0.7810913737255099,0,0,9
64,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.1075856649742598,1.6556515571603585,3.6912219427831823,"['IDI1', 'SQLE', 'HMGCS1', 'SCD', 'INSIG1', 'CYP51A1', 'HMGCR', 'LSS', 'LDLR', 'FDFT1']",0.7867201751242747,0,0,10
65,Nanomaterial induced apoptosis WP2507,0.12219226291308957,2.865,6.022687108455953,"['ENDOG', 'BAX', 'CYCS']",0.8282410257261137,0,0,3
66,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.12219226291308957,2.865,6.022687108455953,"['TGFB1', 'FN1', 'IGFBP7']",0.8282410257261137,0,0,3
67,Biogenic Amine Synthesis WP550,0.12293212216012148,4.296003330557869,9.004951081205489,"['GAD1', 'GAD2']",0.8282410257261137,0,0,2
68,IL1 and megakaryocytes in obesity WP2865,0.12293212216012148,4.296003330557869,9.004951081205489,"['F2R', 'TIMP2']",0.8282410257261137,0,0,2
69,Sulfation Biotransformation Reaction WP692,0.12293212216012148,4.296003330557869,9.004951081205489,"['SULT4A1', 'PAPSS2']",0.8282410257261137,0,0,2
70,Spinal Cord Injury WP2431,0.12478912477861988,1.6480273708970383,3.4297591497252853,"['TGFB1', 'CDKN1B', 'GADD45A', 'APEX1', 'CCNG1', 'OMG', 'XYLT1', 'SLIT3', 'TNFSF13B']",0.8282410257261137,0,0,9
71,Base Excision Repair WP4752,0.1279035896192075,2.0474600524684,4.2105575876751455,"['POLE4', 'NEIL2', 'APEX1', 'POLE2', 'POLE3']",0.8282410257261137,0,0,5
72,DNA Mismatch Repair WP531,0.12919144204702201,2.2925771476230192,4.691667264123452,"['POLE4', 'RPA3', 'POLE2', 'POLE3']",0.8282410257261137,0,0,4
73,Unfolded protein response WP4925,0.12919144204702201,2.2925771476230192,4.691667264123452,"['XBP1', 'HSPA5', 'DDIT3', 'BBC3']",0.8282410257261137,0,0,4
74,Genotoxicity pathway WP4286,0.13743805992111655,1.843000358037952,3.657585219838573,"['RPS27', 'GADD45A', 'BLOC1S2', 'ID2', 'PCDH8', 'PHLDA3']",0.8692028654470614,0,0,6
75,Nuclear Receptors Meta-Pathway WP2882,0.14346845778368167,1.3167866215071973,2.5567256736585606,"['JUN', 'ABCB1', 'CDKN1B', 'TGFB1', 'SRXN1', 'AIP', 'SLC39A13', 'SLC7A11', 'SLC6A1', 'SLC5A4', 'CES4A', 'TGFBR3', 'PSMC5', 'SCD', 'B3GNT5', 'BAX', 'SLC39A7', 'MFGE8', 'CBR3', 'SLC39A3', 'FKBP5', 'FTL']",0.8952431765701736,0,0,22
76,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.14889986313456444,2.1490825688073394,4.0928874751969895,"['TGFBR3', 'TGFB1', 'MFGE8', 'HRAS']",0.9169096835128442,0,0,4
77,miRNA regulation of DNA damage response WP1530,0.15605059161324805,1.6724498327759196,3.106701030054226,"['CDKN1B', 'GADD45A', 'CCNG1', 'CYCS', 'BAX', 'BBC3', 'GADD45G']",0.9331443075474224,0,0,7
78,Cancer immunotherapy by PD-1 blockade WP4585,0.16059995580822656,3.4364696086594506,6.284748792573037,"['JUN', 'HLA-A']",0.9331443075474224,0,0,2
79,Dual hijack model of Vif in HIV infection WP3300,0.16059995580822656,3.4364696086594506,6.284748792573037,"['ELOB', 'RUNX1']",0.9331443075474224,0,0,2
80,Osteoclast Signaling WP12,0.16059995580822656,3.4364696086594506,6.284748792573037,"['AIMP2', 'ATP6V1G1']",0.9331443075474224,0,0,2
81,"GPCRs, Other WP117",0.16150574553705388,1.8690571241924947,3.4076921639282007,"['HTR7', 'ADGRV1', 'HTR1F', 'F2R', 'ADRA1D']",0.9331443075474224,0,0,5
82,NRF2 pathway WP2884,0.16534086124506628,1.456350025813113,2.621060294101674,"['TGFB1', 'SRXN1', 'SLC39A13', 'SLC39A7', 'SLC7A11', 'SLC6A1', 'SLC5A4', 'CES4A', 'SLC39A3', 'FTL', 'CBR3']",0.9436527202767196,0,0,11
83,Peptide GPCRs WP24,0.17349252956404967,2.3436363636363637,4.105162056384057,"['OPRK1', 'NMBR', 'HCRTR2']",0.9782470341683764,0,0,3
84,Breast cancer pathway WP4262,0.19333500410387028,1.3767254408060454,2.2624153506255182,"['SFRP4', 'JUN', 'SHC3', 'FGF9', 'GADD45A', 'TCF7', 'KIT', 'BAX', 'IGF1', 'FGF1', 'HRAS', 'GADD45G']",0.99998491027236,0,0,12
85,Composition of Lipid Particles WP3601,0.19785953412484053,8.587354409317804,13.913213783705178,['LDLR'],0.99998491027236,0,0,1
86,COVID-19 adverse outcome pathway WP4891,0.19785953412484053,8.587354409317804,13.913213783705178,['IL7'],0.99998491027236,0,0,1
87,Drug Induction of Bile Acid Pathway WP2289,0.19785953412484053,8.587354409317804,13.913213783705178,['ABCB1'],0.99998491027236,0,0,1
88,EV release from cardiac cells and their functional effects WP3297,0.19785953412484053,8.587354409317804,13.913213783705178,['RGS16'],0.99998491027236,0,0,1
89,Galanin receptor pathway WP4970,0.1999638682641947,2.8634471273938384,4.6090577203872485,"['CDKN1B', 'PRKCD']",0.99998491027236,0,0,2
90,Glutathione metabolism WP100,0.1999638682641947,2.8634471273938384,4.6090577203872485,"['GPX4', 'GSS']",0.99998491027236,0,0,2
91,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.1999638682641947,2.8634471273938384,4.6090577203872485,"['SFRP1', 'TGFB1']",0.99998491027236,0,0,2
92,Trans-sulfuration pathway WP2333,0.1999638682641947,2.8634471273938384,4.6090577203872485,"['AHCY', 'GOT1']",0.99998491027236,0,0,2
93,Type II interferon signaling (IFNG) WP619,0.20106184473335767,2.148125,3.445899108342535,"['PRKCD', 'HLA-B', 'IFIT2']",0.99998491027236,0,0,3
94,p38 MAPK Signaling Pathway WP400,0.217544986554852,1.6529151149351484,2.52127343436889,"['RPS6KA5', 'DDIT3', 'HSPB1', 'HRAS', 'HMGN1']",0.99998491027236,0,0,5
95,Signaling of Hepatocyte Growth Factor Receptor WP313,0.217544986554852,1.6529151149351484,2.52127343436889,"['JUN', 'ITGA1', 'GAB1', 'PTK2B', 'HRAS']",0.99998491027236,0,0,5
96,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.22564643581685775,1.4330543933054394,2.1335112434976065,"['JUN', 'TGFB1', 'GADD45A', 'TCF7', 'CYCS', 'BAX', 'BBC3', 'GADD45G']",0.99998491027236,0,0,8
97,Pre-implantation embryo WP3527,0.22955638553375216,1.9826923076923078,2.9177430680396226,"['DLX2', 'DDIT3', 'ATP1A1']",0.99998491027236,0,0,3
98,Proteoglycan biosynthesis WP4784,0.22955638553375216,1.9826923076923078,2.9177430680396226,"['XYLT1', 'B4GALT7', 'PAPSS2']",0.99998491027236,0,0,3
99,Zinc homeostasis WP3529,0.22955638553375216,1.9826923076923078,2.9177430680396226,"['SLC39A13', 'SLC39A7', 'SLC39A3']",0.99998491027236,0,0,3
100,Exercise-induced Circadian Regulation WP410,0.23472147764487,1.5168804363850803,2.1984992600581195,"['PER2', 'IDI1', 'DAZAP2', 'SUMO1', 'RBPMS', 'HERPUD1']",0.99998491027236,0,0,6
101,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.23708373970736935,1.7185988323603003,2.4736512539793134,"['LDHA', 'ANGPT2', 'PKM', 'BAX']",0.99998491027236,0,0,4
102,Biomarkers for pyrimidine metabolism disorders WP4584,0.2402603018712297,2.4541453550612586,3.4996906734513464,"['NT5C', 'DPYD']",0.99998491027236,0,0,2
103,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.2402603018712297,2.4541453550612586,3.4996906734513464,"['SFRP1', 'SST']",0.99998491027236,0,0,2
104,Development and heterogeneity of the ILC family WP3893,0.2402603018712297,2.4541453550612586,3.4996906734513464,"['IL7', 'ID2']",0.99998491027236,0,0,2
105,Genes targeted by miRNAs in adipocytes WP1992,0.2402603018712297,2.4541453550612586,3.4996906734513464,"['TMSB4X', 'IGF1']",0.99998491027236,0,0,2
106,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.2402603018712297,2.4541453550612586,3.4996906734513464,"['TULP3', 'SOX4']",0.99998491027236,0,0,2
107,Major receptors targeted by epinephrine and norepinephrine WP4589,0.2402603018712297,2.4541453550612586,3.4996906734513464,"['ADCY10', 'ADRA1D']",0.99998491027236,0,0,2
108,Pyrimidine metabolism and related diseases WP4225,0.2402603018712297,2.4541453550612586,3.4996906734513464,"['NT5C', 'DPYD']",0.99998491027236,0,0,2
109,DNA damage response WP707,0.2526960432404522,1.4733977801646974,2.0267587236881006,"['CDKN1B', 'GADD45A', 'CYCS', 'BAX', 'BBC3', 'GADD45G']",0.99998491027236,0,0,6
110,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.2526960432404522,1.4733977801646974,2.0267587236881006,"['PPP1R14B', 'XBP1', 'MAP1LC3A', 'PPP1R11', 'HSPA5', 'DDIT3']",0.99998491027236,0,0,6
111,Modulators of TCR signaling and T cell activation WP5072,0.2526960432404522,1.4733977801646974,2.0267587236881006,"['FIBP', 'CDKN1B', 'NDUFB10', 'ELOB', 'RNF7', 'CD247']",0.99998491027236,0,0,6
112,One-carbon metabolism and related pathways WP3940,0.25778572769713987,1.534551633675173,2.0802789399162855,"['GPX4', 'CHDH', 'GAD1', 'GSS', 'GAD2']",0.99998491027236,0,0,5
113,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.2587264228650464,1.840892857142857,2.488857795189167,"['HTR7', 'RPS6KA5', 'HTR4']",0.99998491027236,0,0,3
114,Sleep regulation WP3591,0.2587264228650464,1.840892857142857,2.488857795189167,"['AHCY', 'CRH', 'HCRTR2']",0.99998491027236,0,0,3
115,Oncostatin M Signaling Pathway WP2374,0.26323776903875123,1.3992377693085478,1.8675592791469044,"['CDKN1B', 'PRKCH', 'PRKCD', 'TIMP3', 'PTK2B', 'HRAS', 'LDLR']",0.99998491027236,0,0,7
116,Kynurenine Pathway and links to Cellular Senescence WP5044,0.28086638806749176,2.1471690258118237,2.7266388647973647,"['KMO', 'ACMSD']",0.99998491027236,0,0,2
117,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.28159554036940954,4.293261231281198,5.440779083443132,['GSS'],0.99998491027236,0,0,1
118,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.28159554036940954,4.293261231281198,5.440779083443132,['ABCB1'],0.99998491027236,0,0,1
119,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.28159554036940954,4.293261231281198,5.440779083443132,['BAX'],0.99998491027236,0,0,1
120,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.28159554036940954,4.293261231281198,5.440779083443132,['CD247'],0.99998491027236,0,0,1
121,Platelet-mediated interactions with vascular and circulating cells WP4462,0.28159554036940954,4.293261231281198,5.440779083443132,['TGFB1'],0.99998491027236,0,0,1
122,Tgif disruption of Shh signaling WP3674,0.28159554036940954,4.293261231281198,5.440779083443132,['GLI3'],0.99998491027236,0,0,1
123,Vitamin B6-dependent and responsive disorders WP4228,0.28159554036940954,4.293261231281198,5.440779083443132,['PNPO'],0.99998491027236,0,0,1
124,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.28833882388695364,1.718,2.1365374738125036,"['B3GALNT1', 'B3GALT2', 'B3GALT1']",0.99998491027236,0,0,3
125,IL-7 signaling pathway WP205,0.31817895439103006,1.61046875,1.8442142857610728,"['CDKN1B', 'IL7', 'PTK2B']",0.99998491027236,0,0,3
126,BMP Signaling Pathway in Eyelid Development WP3927,0.3212789345311065,1.9084096586178185,2.166895308365894,"['JUN', 'SFRP1']",0.99998491027236,0,0,2
127,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.3212789345311065,1.9084096586178185,2.166895308365894,"['RYR1', 'CCK']",0.99998491027236,0,0,2
128,Cori Cycle WP1946,0.3212789345311065,1.9084096586178185,2.166895308365894,"['LDHA', 'PGAM1']",0.99998491027236,0,0,2
129,Overview of nanoparticle effects WP3287,0.3212789345311065,1.9084096586178185,2.166895308365894,"['FN1', 'BAX']",0.99998491027236,0,0,2
130,TYROBP causal network in microglia WP3945,0.3212789345311065,1.9084096586178185,2.166895308365894,"['DPYD', 'LHFPL2']",0.99998491027236,0,0,2
131,Myometrial relaxation and contraction pathways WP289,0.33624224041922834,1.1761521450685537,1.2819157744535792,"['RYR1', 'JUN', 'PRKCH', 'IGFBP5', 'RGS16', 'PRKCD', 'ACTG1', 'PRKAR1A', 'GNG4', 'CRH', 'PRKD1', 'ATF5', 'CORIN']",0.99998491027236,0,0,13
132,Synaptic Vesicle Pathway WP2267,0.3469265452083116,1.28859649122807,1.3641626330484384,"['RAB3A', 'SLC32A1', 'SLC17A7', 'PARK7', 'SYN3', 'CPLX3']",0.99998491027236,0,0,6
133,Translation Factors WP107,0.3469265452083116,1.28859649122807,1.3641626330484384,"['EIF4A2', 'EEF1B2', 'EEF1G', 'EIF3I', 'EIF4H', 'EIF3D']",0.99998491027236,0,0,6
134,Glycosylation and related congenital defects WP4521,0.3480517297008348,1.5155882352941177,1.5995581309365245,"['DPM3', 'MPI', 'MPDU1']",0.99998491027236,0,0,3
135,Adipogenesis WP236,0.35110612526453877,1.2082679020100502,1.2646538381674475,"['LIPE', 'SFRP4', 'WWTR1', 'TGFB1', 'GADD45A', 'SCD', 'DDIT3', 'NDN', 'IGF1']",0.99998491027236,0,0,9
136,Bile acids synthesis and enterohepatic circulation  WP4389,0.35659678598670125,2.8618968386023296,2.9510437418180646,['LDLR'],0.99998491027236,0,0,1
137,Blood Clotting Cascade WP272,0.35659678598670125,2.8618968386023296,2.9510437418180646,['PLAT'],0.99998491027236,0,0,1
138,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.35659678598670125,2.8618968386023296,2.9510437418180646,['ID2'],0.99998491027236,0,0,1
139,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.35659678598670125,2.8618968386023296,2.9510437418180646,['FN1'],0.99998491027236,0,0,1
140,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.35659678598670125,2.8618968386023296,2.9510437418180646,['LDLR'],0.99998491027236,0,0,1
141,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.35659678598670125,2.8618968386023296,2.9510437418180646,['VEGFB'],0.99998491027236,0,0,1
142,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.35659678598670125,2.8618968386023296,2.9510437418180646,['STRADB'],0.99998491027236,0,0,1
143,Nanoparticle triggered regulated necrosis WP2513,0.35659678598670125,2.8618968386023296,2.9510437418180646,['FTL'],0.99998491027236,0,0,1
144,Somatic sex determination WP4814,0.35659678598670125,2.8618968386023296,2.9510437418180646,['FGF9'],0.99998491027236,0,0,1
145,Airway smooth muscle cell contraction WP4962,0.3610962609371095,1.7174021648626145,1.7493642306043808,"['RYR1', 'MYLK']",0.99998491027236,0,0,2
146,ERK Pathway in Huntington's Disease WP3853,0.3610962609371095,1.7174021648626145,1.7493642306043808,"['RPS6KA5', 'HRAS']",0.99998491027236,0,0,2
147,Phytochemical activity on NRF2 transcriptional activation WP3,0.3610962609371095,1.7174021648626145,1.7493642306043808,"['AIMP2', 'SLC7A11']",0.99998491027236,0,0,2
148,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.3610962609371095,1.7174021648626145,1.7493642306043808,"['TGFB1', 'FN1']",0.99998491027236,0,0,2
149,Type II diabetes mellitus WP1584,0.3610962609371095,1.7174021648626145,1.7493642306043808,"['SURF1', 'PRKCD']",0.99998491027236,0,0,2
150,Urea cycle and metabolism of amino groups WP497,0.3610962609371095,1.7174021648626145,1.7493642306043808,"['ODC1', 'SRM']",0.99998491027236,0,0,2
151,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.3777819986009068,1.43125,1.3932330988697215,"['RAB3A', 'HSPB1', 'RAB11A']",0.99998491027236,0,0,3
152,Lung fibrosis WP3624,0.3777819986009068,1.43125,1.3932330988697215,"['TGFB1', 'IGF1', 'FGF1']",0.99998491027236,0,0,3
153,Parkinson's disease pathway WP2371,0.3835815026492552,1.3212292294861103,1.2660060195400518,"['PINK1', 'CYCS', 'UBE2L6', 'PARK7']",0.99998491027236,0,0,4
154,ATM Signaling Network in Development and Disease  WP3878,0.38551362968076697,1.263011882549347,1.2038760631333594,"['DCLRE1C', 'KAT5', 'HSPB1', 'HMGN1', 'CDK5R1']",0.99998491027236,0,0,5
155,Eukaryotic Transcription Initiation WP405,0.38551362968076697,1.263011882549347,1.2038760631333594,"['TAF13', 'POLR2E', 'TAF7', 'POLR2I', 'POLR2K']",0.99998491027236,0,0,5
156,Kallmann's Syndrome WP5074,0.40000251773911333,1.5611233063356293,1.4304329906859767,"['ANOS1', 'ASCL1']",0.99998491027236,0,0,2
157,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.40000251773911333,1.5611233063356293,1.4304329906859767,"['FGF9', 'GADD45G']",0.99998491027236,0,0,2
158,Omega-9 FA synthesis WP4724,0.40000251773911333,1.5611233063356293,1.4304329906859767,"['SCD', 'ACOT2']",0.99998491027236,0,0,2
159,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.40000251773911333,1.5611233063356293,1.4304329906859767,"['BAX', 'BCL2L14']",0.99998491027236,0,0,2
160,Fas ligand pathway and stress induction of heat shock proteins WP314,0.40817949764599026,1.27217125382263,1.139926833467063,"['JUN', 'HSPB1', 'CYCS', 'ACTG1']",0.99998491027236,0,0,4
161,Integrated Cancer Pathway WP1971,0.40817949764599026,1.27217125382263,1.139926833467063,"['CDKN1B', 'BAX', 'BACH1', 'BBC3']",0.99998491027236,0,0,4
162,Target Of Rapamycin (TOR) Signaling WP1471,0.40817949764599026,1.27217125382263,1.139926833467063,"['IDI1', 'RRAGA', 'DDIT4', 'HMGCR']",0.99998491027236,0,0,4
163,Androgen receptor signaling pathway WP138,0.4126894551734115,1.1367499261010936,1.006091768392166,"['JUN', 'SUMO1', 'KAT5', 'BAG1', 'RNF6', 'PARK7', 'CALR', 'FKBP4', 'ETV5']",0.99998491027236,0,0,9
164,Farnesoid X receptor pathway WP2879,0.42377373761026604,2.1462146422628954,1.8426446082808066,['FKBP5'],0.99998491027236,0,0,1
165,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.42377373761026604,2.1462146422628954,1.8426446082808066,['ALDH1L1'],0.99998491027236,0,0,1
166,Inflammatory Response Pathway WP453,0.42377373761026604,2.1462146422628954,1.8426446082808066,['FN1'],0.99998491027236,0,0,1
167,Linoleic acid metabolism known to be affected by coronavirus infection WP4853,0.42377373761026604,2.1462146422628954,1.8426446082808066,['ACOT2'],0.99998491027236,0,0,1
168,Liver X receptor pathway WP2874,0.42377373761026604,2.1462146422628954,1.8426446082808066,['SCD'],0.99998491027236,0,0,1
169,Mitochondrial fatty acid synthesis pathway WP4317,0.42377373761026604,2.1462146422628954,1.8426446082808066,['HSD17B12'],0.99998491027236,0,0,1
170,NAD Biosynthesis II (from tryptophan) WP2485,0.42377373761026604,2.1462146422628954,1.8426446082808066,['KMO'],0.99998491027236,0,0,1
171,Peroxiredoxin 2 induced ovarian failure WP4873,0.42377373761026604,2.1462146422628954,1.8426446082808066,['BAX'],0.99998491027236,0,0,1
172,Vitamin D Metabolism WP1531,0.42377373761026604,2.1462146422628954,1.8426446082808066,['DHCR7'],0.99998491027236,0,0,1
173,Apoptosis WP254,0.4243808328226848,1.170995670995671,1.0036885359696766,"['HRK', 'JUN', 'CYCS', 'BAX', 'IGF1', 'BBC3']",0.99998491027236,0,0,6
174,Endometrial cancer WP4155,0.4243808328226848,1.170995670995671,1.0036885359696766,"['GADD45A', 'TCF7', 'BAX', 'FGF1', 'HRAS', 'GADD45G']",0.99998491027236,0,0,6
175,p53 transcriptional gene network WP4963,0.4284941462502719,1.1926126878130217,1.0107132564262777,"['GADD45A', 'CCNG1', 'BAX', 'SLC7A11', 'BBC3']",0.99998491027236,0,0,5
176,Complement and Coagulation Cascades WP558,0.43775416871715633,1.4308909242298085,1.182055822806554,"['F2R', 'PLAT']",0.99998491027236,0,0,2
177,miRNA regulation of p53 pathway in prostate cancer WP3982,0.43775416871715633,1.4308909242298085,1.182055822806554,"['BAX', 'BBC3']",0.99998491027236,0,0,2
178,Pregnane X receptor pathway WP2876,0.43775416871715633,1.4308909242298085,1.182055822806554,"['PSMC5', 'ABCB1']",0.99998491027236,0,0,2
179,Purinergic signaling WP4900,0.43775416871715633,1.4308909242298085,1.182055822806554,"['P2RY12', 'P2RY14']",0.99998491027236,0,0,2
180,Triacylglyceride synthesis WP325,0.43775416871715633,1.4308909242298085,1.182055822806554,"['LIPE', 'AGPAT1']",0.99998491027236,0,0,2
181,Vitamin B12 metabolism WP1533,0.43775416871715633,1.4308909242298085,1.182055822806554,"['PLAT', 'LDLR']",0.99998491027236,0,0,2
182,Phosphodiesterases in neuronal function WP4222,0.4497726005818675,1.1602671118530885,0.9270686868230811,"['ADCY10', 'PDE10A', 'PDE1A', 'PDE3A', 'PDE5A']",0.99998491027236,0,0,5
183,TGF-beta Receptor Signaling WP560,0.4566808621301543,1.1842052284950102,0.9281450818287518,"['TGFBR3', 'JUN', 'TGFB1', 'HRAS']",0.99998491027236,0,0,4
184,Calcium Regulation in the Cardiac Cell WP536,0.46817360941206976,1.06219325352515,0.8061155524584378,"['RYR1', 'GJD2', 'PRKCH', 'PRKAR1A', 'GNG4', 'RGS16', 'CHRM5', 'PRKCD', 'ADRA1D', 'ATP1B2', 'PRKD1', 'CALR']",0.99998491027236,0,0,12
185,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.4741683563682268,1.3206942932171908,0.9854926229682388,"['JUN', 'MYLK']",0.99998491027236,0,0,2
186,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.4741683563682268,1.3206942932171908,0.9854926229682388,"['EIF3I', 'EIF3D']",0.99998491027236,0,0,2
187,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.4741683563682268,1.3206942932171908,0.9854926229682388,"['JUN', 'SRXN1']",0.99998491027236,0,0,2
188,Striated Muscle Contraction Pathway WP383,0.4741683563682268,1.3206942932171908,0.9854926229682388,"['TNNT2', 'ACTG1']",0.99998491027236,0,0,2
189,Cytosolic DNA-sensing pathway WP4655,0.48043359027136395,1.1446205170975814,0.8390826927555702,"['POLR1C', 'POLR2E', 'POLR2K', 'POLR2L']",0.99998491027236,0,0,4
190,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.4839420325943288,1.7168053244592345,1.2460403884753515,['TCF7'],0.99998491027236,0,0,1
191,Biomarkers for urea cycle disorders WP4583,0.4839420325943288,1.7168053244592345,1.2460403884753515,['GOT1'],0.99998491027236,0,0,1
192,Caloric restriction and aging WP4191,0.4839420325943288,1.7168053244592345,1.2460403884753515,['IGF1'],0.99998491027236,0,0,1
193,"Degradation pathway of sphingolipids, including diseases WP4153",0.4839420325943288,1.7168053244592345,1.2460403884753515,['NEU1'],0.99998491027236,0,0,1
194,Disorders of Folate Metabolism and Transport WP4259,0.4839420325943288,1.7168053244592345,1.2460403884753515,['ALDH1L1'],0.99998491027236,0,0,1
195,Eicosanoid Synthesis WP167,0.4839420325943288,1.7168053244592345,1.2460403884753515,['PTGES2'],0.99998491027236,0,0,1
196,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.4839420325943288,1.7168053244592345,1.2460403884753515,['AHCY'],0.99998491027236,0,0,1
197,Selective expression of chemokine receptors during T-cell polarization WP4494,0.4839420325943288,1.7168053244592345,1.2460403884753515,['TGFB1'],0.99998491027236,0,0,1
198,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.4839420325943288,1.7168053244592345,1.2460403884753515,['JUN'],0.99998491027236,0,0,1
199,Transcriptional cascade regulating adipogenesis WP4211,0.4839420325943288,1.7168053244592345,1.2460403884753515,['DDIT3'],0.99998491027236,0,0,1
200,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.491639810926646,1.1005522023885963,0.7814018830562603,"['SFRP4', 'SFRP1', 'JUN', 'TCF7', 'CXXC4']",0.99998491027236,0,0,5
201,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.491639810926646,1.1005522023885963,0.7814018830562603,"['IFI27L2', 'JUN', 'PRKCH', 'PRKCD', 'HRAS']",0.99998491027236,0,0,5
202,Bladder cancer WP2828,0.49245536044910065,1.170568181818182,0.8291736819782624,"['RPS6KA5', 'DAPK2', 'HRAS']",0.99998491027236,0,0,3
203,Oxidative Damage WP3941,0.49245536044910065,1.170568181818182,0.8291736819782624,"['CDKN1B', 'GADD45A', 'CYCS']",0.99998491027236,0,0,3
204,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.509112905679167,1.2262400380635186,0.8278168304750494,"['H3F3B', 'H2AFZ']",0.99998491027236,0,0,2
205,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.509112905679167,1.2262400380635186,0.8278168304750494,"['BAX', 'BBC3']",0.99998491027236,0,0,2
206,Ovarian infertility WP34,0.509112905679167,1.2262400380635186,0.8278168304750494,"['CDKN1B', 'INHA']",0.99998491027236,0,0,2
207,"Relationship between inflammation, COX-2 and EGFR WP4483",0.509112905679167,1.2262400380635186,0.8278168304750494,"['PTGES2', 'HRAS']",0.99998491027236,0,0,2
208,SARS-CoV-2 mitochondrial interactions WP5038,0.509112905679167,1.2262400380635186,0.8278168304750494,"['NDUFB9', 'PHB']",0.99998491027236,0,0,2
209,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.5093847290754172,1.015770756326059,0.685189885557501,"['CDKN1B', 'ANGPT2', 'COL11A1', 'F2R', 'FN1', 'VEGFB', 'IGF1', 'HIF3A', 'FGF1', 'LIPE', 'RELN', 'FGF9', 'COL5A1', 'PIK3IP1', 'GNG4', 'DDIT4', 'PDGFC', 'KIT', 'COL5A2', 'HRAS']",0.99998491027236,0,0,20
210,Alpha 6 Beta 4 signaling pathway WP244,0.5195154577139196,1.1195652173913044,0.7331570383903301,"['PRKCD', 'GAB1', 'HRAS']",0.99998491027236,0,0,3
211,Complement system WP2806,0.5195154577139196,1.1195652173913044,0.7331570383903301,"['RPS19', 'CD59', 'CALR']",0.99998491027236,0,0,3
212,Nanoparticle-mediated activation of receptor signaling WP2643,0.5195154577139196,1.1195652173913044,0.7331570383903301,"['ITGA1', 'FN1', 'HRAS']",0.99998491027236,0,0,3
213,VEGFA-VEGFR2 Signaling Pathway WP3888,0.5321438167171728,0.9977301688435808,0.6294095903206745,"['SET', 'TRAF3IP2', 'EPB41', 'HSPB1', 'RPL10A', 'APOLD1', 'RPL7', 'HERPUD1', 'ACTG1', 'SCUBE2', 'LDHA', 'RPS6KA5', 'RPL18A', 'TMSB4X', 'RPLP2', 'DNAJB9', 'PTK2B', 'IGFBP7', 'MYH11', 'CCT7', 'HRAS', 'JUN', 'TRPC3', 'PRKCD', 'FN1', 'GAB1', 'RPL13A', 'RAB11A', 'CYCS', 'RPL27', 'PRKD1', 'RPL26', 'CALR', 'EIF3D', 'ARF6']",0.99998491027236,0,0,35
214,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.5322822111613706,1.0466631377499085,0.6600063676289859,"['JUN', 'CDKN1B', 'TMSB4X', 'FN1', 'MYLK']",0.99998491027236,0,0,5
215,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.5378323470297077,1.430532445923461,0.8872282251377241,['GALNT3'],0.99998491027236,0,0,1
216,HIF1A and PPARG regulation of glycolysis WP2456,0.5378323470297077,1.430532445923461,0.8872282251377241,['LDHA'],0.99998491027236,0,0,1
217,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.5378323470297077,1.430532445923461,0.8872282251377241,['TGFB1'],0.99998491027236,0,0,1
218,Neuroinflammation WP4919,0.5378323470297077,1.430532445923461,0.8872282251377241,['JUN'],0.99998491027236,0,0,1
219,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.5378323470297077,1.430532445923461,0.8872282251377241,['ANAPC11'],0.99998491027236,0,0,1
220,Thiamine metabolic pathways WP4297,0.5378323470297077,1.430532445923461,0.8872282251377241,['BCKDK'],0.99998491027236,0,0,1
221,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.5424977504606229,1.1443796835970026,0.6998698167864685,"['TICAM2', 'PLAT']",0.99998491027236,0,0,2
222,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.5424977504606229,1.1443796835970026,0.6998698167864685,"['TGFBR3', 'ANGPT2']",0.99998491027236,0,0,2
223,BDNF-TrkB Signaling WP3676,0.545771594489293,1.0728125,0.6496466686201166,"['TRPC3', 'GAB1', 'HRAS']",0.99998491027236,0,0,3
224,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.545771594489293,1.0728125,0.6496466686201166,"['PRKCH', 'PRKCD', 'HRAS']",0.99998491027236,0,0,3
225,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.5489587059313111,1.0402608234134505,0.6238777636340821,"['TGFBR3', 'JUN', 'TGFB1', 'HRAS']",0.99998491027236,0,0,4
226,DNA damage response (only ATM dependent) WP710,0.560606274137534,0.9948699290522103,0.5757674894474771,"['JUN', 'TGFB1', 'CDKN1B', 'TCF7', 'BAX', 'HRAS', 'LDLR', 'BBC3']",0.99998491027236,0,0,8
227,G Protein Signaling Pathways WP35,0.560606274137534,0.9948699290522103,0.5757674894474771,"['PRKCH', 'PRKD3', 'PRKAR1A', 'GNG4', 'PDE1A', 'PRKCD', 'PRKD1', 'HRAS']",0.99998491027236,0,0,8
228,Glucocorticoid Receptor Pathway WP2880,0.5707267346890083,1.0095667958592944,0.5662102444029552,"['TGFBR3', 'JUN', 'B3GNT5', 'MFGE8']",0.99998491027236,0,0,4
229,T-cell receptor (TCR) signaling pathway WP69,0.5726002718084099,0.9900713321765954,0.5520315100074391,"['JUN', 'TGFB1', 'PRKCD', 'PTK2B', 'CD247', 'HRAS']",0.99998491027236,0,0,6
230,Oxidation by Cytochrome P450 WP43,0.5742675953238746,1.072751873438801,0.5950123367318022,"['CYB5R1', 'CYP51A1']",0.99998491027236,0,0,2
231,Trans-sulfuration and one-carbon metabolism WP2525,0.5742675953238746,1.072751873438801,0.5950123367318022,"['AHCY', 'GSS']",0.99998491027236,0,0,2
232,Tryptophan metabolism WP465,0.5742675953238746,1.072751873438801,0.5950123367318022,"['DHCR24', 'ACMSD']",0.99998491027236,0,0,2
233,White fat cell differentiation WP4149,0.5742675953238746,1.072751873438801,0.5950123367318022,"['DDIT3', 'NR2F2']",0.99998491027236,0,0,2
234,Estrogen Receptor Pathway WP2881,0.586099238516891,1.2260518183979083,0.655037990525124,['JUN'],0.99998491027236,0,0,1
235,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.586099238516891,1.2260518183979083,0.655037990525124,['ELOB'],0.99998491027236,0,0,1
236,ID signaling pathway WP53,0.586099238516891,1.2260518183979083,0.655037990525124,['ID2'],0.99998491027236,0,0,1
237,Leptin and adiponectin WP3934,0.586099238516891,1.2260518183979083,0.655037990525124,['LEPR'],0.99998491027236,0,0,1
238,Mitochondrial CII Assembly WP4920,0.586099238516891,1.2260518183979083,0.655037990525124,['SDHAF1'],0.99998491027236,0,0,1
239,Serotonin and anxiety-related events WP3944,0.586099238516891,1.2260518183979083,0.655037990525124,['CRH'],0.99998491027236,0,0,1
240,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.586099238516891,1.2260518183979083,0.655037990525124,['TGFB1'],0.99998491027236,0,0,1
241,G1 to S cell cycle control WP45,0.5918939328034516,0.9806267127368045,0.5142679367572097,"['CDKN1B', 'GADD45A', 'RPA3', 'POLE2']",0.99998491027236,0,0,4
242,Angiogenesis WP1539,0.6043956484630608,1.009550864475682,0.508335359330929,"['TIMP2', 'TIMP3']",0.99998491027236,0,0,2
243,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.6043956484630608,1.009550864475682,0.508335359330929,"['NDUFA13', 'AAMP']",0.99998491027236,0,0,2
244,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.6087314089436022,0.9532554257095158,0.4731751597101251,"['ANGPT2', 'FN1', 'BAX', 'HRAS', 'ANGPTL1']",0.99998491027236,0,0,5
245,Nucleotide Excision Repair WP4753,0.6124315375608533,0.9532944120100083,0.4674175222077647,"['POLE4', 'RPA3', 'POLE2', 'POLE3']",0.99998491027236,0,0,4
246,Regulation of Microtubule Cytoskeleton WP2038,0.6124315375608533,0.9532944120100083,0.4674175222077647,"['SPRED1', 'PARD6A', 'CFL2', 'TESK2']",0.99998491027236,0,0,4
247,DNA Repair Pathways Full Network WP4946,0.6185740959374286,0.9424942199460221,0.4527160665725168,"['FANCI', 'POLE4', 'DCLRE1C', 'NEIL2', 'CENPX', 'RPA3', 'POLE2', 'APEX1', 'POLE3', 'FAAP100']",0.99998491027236,0,0,10
248,Copper homeostasis WP3286,0.6192304302675409,0.9533333333333334,0.45691151546540304,"['JUN', 'COX17', 'ATOX1']",0.99998491027236,0,0,3
249,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.6192304302675409,0.9533333333333334,0.45691151546540304,"['IFITM3', 'JUN', 'DDIT3']",0.99998491027236,0,0,3
250,IL-2 signaling pathway WP49,0.6192304302675409,0.9533333333333334,0.45691151546540304,"['JUN', 'PTK2B', 'HRAS']",0.99998491027236,0,0,3
251,Pathways Regulating Hippo Signaling WP4540,0.620986672551019,0.9381924122073578,0.4469977016802367,"['PRKCH', 'PRKD3', 'PRKAR1A', 'PRKCD', 'TCF7', 'KIT', 'CDH18']",0.99998491027236,0,0,7
252,15q11.2 copy number variation syndrome WP4940,0.6293290699055842,1.0726913477537439,0.49676443098987977,['TUBGCP4'],0.99998491027236,0,0,1
253,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.6293290699055842,1.0726913477537439,0.49676443098987977,['GABBR1'],0.99998491027236,0,0,1
254,Hypertrophy Model WP516,0.6293290699055842,1.0726913477537439,0.49676443098987977,['WDR1'],0.99998491027236,0,0,1
255,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.6293290699055842,1.0726913477537439,0.49676443098987977,['JUN'],0.99998491027236,0,0,1
256,miRNAs involved in DNA damage response WP1545,0.6293290699055842,1.0726913477537439,0.49676443098987977,['CDKN1B'],0.99998491027236,0,0,1
257,Non-homologous end joining WP438,0.6293290699055842,1.0726913477537439,0.49676443098987977,['DCLRE1C'],0.99998491027236,0,0,1
258,Purine metabolism WP4792,0.6293290699055842,1.0726913477537439,0.49676443098987977,['PRPS1'],0.99998491027236,0,0,1
259,TCA cycle in senescence WP5050,0.6293290699055842,1.0726913477537439,0.49676443098987977,['GOT1'],0.99998491027236,0,0,1
260,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.6323166458782531,0.9274395329441201,0.4251058107091926,"['ADCY10', 'TGFB1', 'BANF1', 'HRAS']",0.99998491027236,0,0,4
261,Endothelin Pathways WP2197,0.6328782828129452,0.9533721898417985,0.4361460033217396,"['ADCY10', 'MYLK']",0.99998491027236,0,0,2
262,Genes controlling nephrogenesis WP4823,0.6328782828129452,0.9533721898417985,0.4361460033217396,"['ETV4', 'GLI3']",0.99998491027236,0,0,2
263,NRF2-ARE regulation WP4357,0.6328782828129452,0.9533721898417985,0.4361460033217396,"['AIMP2', 'SLC7A11']",0.99998491027236,0,0,2
264,Ebola Virus Pathway on Host WP4217,0.6337343365536531,0.9271966527196652,0.4229179810764381,"['ITGA1', 'HLA-B', 'HLA-C', 'HLA-A', 'HLA-F', 'MFGE8', 'ASGR1', 'ACTG1']",0.99998491027236,0,0,8
265,Amino Acid metabolism WP3925,0.6392540971860077,0.9189939133548156,0.4112068182852189,"['LDHA', 'PKM', 'GOT1', 'GSS', 'ODC1', 'SRM']",0.99998491027236,0,0,6
266,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.6418430117868563,0.9191964285714286,0.407582299471065,"['MAP1LC3A', 'IGFBP5', 'IGF1']",0.99998491027236,0,0,3
267,Focal Adhesion WP306,0.6522016441335081,0.9210778526286547,0.3936700509727035,"['JUN', 'SHC3', 'ITGA1', 'FN1', 'VEGFB', 'TESK2', 'IGF1', 'MYLK', 'ACTG1', 'RELN', 'PDGFC', 'COL5A2', 'HRAS']",0.99998491027236,0,0,13
268,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.6610394722150859,0.8934161101836394,0.36982220579714564,"['SFRP4', 'SFRP1', 'JUN', 'TCF7', 'CXXC4']",0.99998491027236,0,0,5
269,Aryl Hydrocarbon Receptor Netpath WP2586,0.6634916799142575,0.8874137931034483,0.36405171599231034,"['CDKN1B', 'AIP', 'HRAS']",0.99998491027236,0,0,3
270,Nephrotic syndrome WP4758,0.6634916799142575,0.8874137931034483,0.36405171599231034,"['ANLN', 'GPC5', 'WDR73']",0.99998491027236,0,0,3
271,Canonical and non-canonical TGF-B signaling WP3874,0.6680471088054601,0.9534109816971714,0.3846027348505465,['TGFB1'],0.99998491027236,0,0,1
272,Fatty acid transporters WP5061,0.6680471088054601,0.9534109816971714,0.3846027348505465,['FABP3'],0.99998491027236,0,0,1
273,Ganglio Sphingolipid Metabolism WP1423,0.6680471088054601,0.9534109816971714,0.3846027348505465,['B3GALT1'],0.99998491027236,0,0,1
274,"GPCRs, Class B Secretin-like WP334",0.6680471088054601,0.9534109816971714,0.3846027348505465,['ADGRG2'],0.99998491027236,0,0,1
275,Hedgehog Signaling Pathway Netpath WP47,0.6680471088054601,0.9534109816971714,0.3846027348505465,['GLI3'],0.99998491027236,0,0,1
276,Mammalian disorder of sexual development WP4842,0.6680471088054601,0.9534109816971714,0.3846027348505465,['FGF9'],0.99998491027236,0,0,1
277,RalA downstream regulated genes WP2290,0.6680471088054601,0.9534109816971714,0.3846027348505465,['HRAS'],0.99998491027236,0,0,1
278,Small cell lung cancer WP4658,0.6701470312478861,0.8871316221588453,0.35508165395104885,"['CDKN1B', 'GADD45A', 'FN1', 'CYCS', 'BAX', 'GADD45G']",0.99998491027236,0,0,6
279,Melanoma WP4685,0.6774308833379461,0.8750979523695955,0.3408049273948488,"['GADD45A', 'KIT', 'BAX', 'HRAS', 'GADD45G']",0.99998491027236,0,0,5
280,IL-3 signaling pathway WP286,0.6841727420911997,0.85775,0.32555459193718367,"['JUN', 'TGFB1', 'HRAS']",0.99998491027236,0,0,3
281,Wnt signaling pathway and pluripotency WP399,0.6849456798126224,0.8720105348116053,0.3299825147902573,"['JUN', 'PRKCH', 'PRKCD', 'TCF7', 'PRKD1', 'LDLR']",0.99998491027236,0,0,6
282,Ethanol effects on histone modifications WP3996,0.6849820825015263,0.8578684429641965,0.32458533281707713,"['AHCY', 'HAT1']",0.99998491027236,0,0,2
283,MTHFR deficiency WP4288,0.6849820825015263,0.8578684429641965,0.32458533281707713,"['CHDH', 'CYCS']",0.99998491027236,0,0,2
284,Gastrin signaling pathway WP4659,0.6870526681802832,0.8793047956227873,0.3300420655806156,"['JUN', 'PRKCH', 'CDKN1B', 'KAT5', 'PRKCD', 'KIT', 'PRKD1', 'HRAS']",0.99998491027236,0,0,8
285,Cell Differentiation - Index expanded WP2023,0.7027238884251913,0.8579866888519134,0.302690175992834,['ID2'],0.99998491027236,0,0,1
286,Leptin Insulin Overlap WP3935,0.7027238884251913,0.8579866888519134,0.302690175992834,['LEPR'],0.99998491027236,0,0,1
287,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.7027238884251913,0.8579866888519134,0.302690175992834,['SOX4'],0.99998491027236,0,0,1
288,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.7027238884251913,0.8579866888519134,0.302690175992834,['SFRP4'],0.99998491027236,0,0,1
289,Riboflavin and CoQ disorders WP5037,0.7027238884251913,0.8579866888519134,0.302690175992834,['RFK'],0.99998491027236,0,0,1
290,Serotonin and anxiety WP3947,0.7027238884251913,0.8579866888519134,0.302690175992834,['CRH'],0.99998491027236,0,0,1
291,Tryptophan catabolism leading to NAD+ production WP4210,0.7027238884251913,0.8579866888519134,0.302690175992834,['KMO'],0.99998491027236,0,0,1
292,Neovascularisation processes WP4331,0.7086743583470823,0.8169382657309385,0.28132017093305456,"['TGFB1', 'KIT']",0.99998491027236,0,0,2
293,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.7086743583470823,0.8169382657309385,0.28132017093305456,"['TGFB1', 'BAX']",0.99998491027236,0,0,2
294,Sphingolipid pathway WP1422,0.7086743583470823,0.8169382657309385,0.28132017093305456,"['CERS4', 'SERINC1']",0.99998491027236,0,0,2
295,Osteoblast differentiation WP4787,0.7132149201742214,0.8432556801840667,0.2849972077461209,"['PRKCH', 'FGF9', 'PRKCD', 'PRKD1', 'FGF1', 'GLI3']",0.99998491027236,0,0,6
296,Acute viral myocarditis WP4298,0.7215100419199687,0.8166329083760276,0.2665563169032526,"['ENDOG', 'TGFB1', 'CYCS', 'BAX']",0.99998491027236,0,0,4
297,Non-small cell lung cancer WP4255,0.7233642793482699,0.8243707461153204,0.26696615105528265,"['GADD45A', 'CYCS', 'BAX', 'HRAS', 'GADD45G']",0.99998491027236,0,0,5
298,Glioblastoma signaling pathways WP2261,0.7266781857677345,0.8295739348370927,0.2648593643263785,"['CDKN1B', 'PRKCH', 'PRKCD', 'GAB1', 'SPRY2', 'HRAS']",0.99998491027236,0,0,6
299,Lipid Metabolism Pathway WP3965,0.7308574618795345,0.7797290137007039,0.24447376230586754,"['LIPE', 'PRKAR1A']",0.99998491027236,0,0,2
300,Signal transduction through IL1R WP4496,0.7308574618795345,0.7797290137007039,0.24447376230586754,"['JUN', 'TGFB1']",0.99998491027236,0,0,2
301,GDNF/RET signaling axis WP4830,0.7337809070283832,0.7799122674330661,0.2414177764767232,['GLI3'],0.99998491027236,0,0,1
302,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.7337809070283832,0.7799122674330661,0.2414177764767232,['ABCB1'],0.99998491027236,0,0,1
303,Omega-3/Omega-6 FA synthesis WP4723,0.7337809070283832,0.7799122674330661,0.2414177764767232,['ACOT2'],0.99998491027236,0,0,1
304,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.7337809070283832,0.7799122674330661,0.2414177764767232,['LDHA'],0.99998491027236,0,0,1
305,Regulation of Actin Cytoskeleton WP51,0.734491490109174,0.8483480368154167,0.2617805813618723,"['FGF9', 'CFL2', 'TMSB4X', 'CHRM5', 'F2R', 'ITGA1', 'FN1', 'FGF1', 'MYLK', 'ACTG1']",0.99998491027236,0,0,10
306,Circadian rhythm related genes WP3594,0.7357120124359607,0.8566750629722922,0.2629277327625026,"['PER2', 'JUN', 'HTR7', 'AHCY', 'DBP', 'ID2', 'CRH', 'RBM4B', 'ATF5', 'RPS27A', 'HCRTR2', 'CIART']",0.99998491027236,0,0,12
307,Insulin Signaling WP481,0.7357120124359607,0.8566750629722922,0.2629277327625026,"['LIPE', 'XBP1', 'JUN', 'RPS6KA5', 'PRKCH', 'SHC3', 'PRKCD', 'GAB1', 'GYG1', 'HRAS', 'PFKM', 'ARF6']",0.99998491027236,0,0,12
308,Retinoblastoma gene in cancer WP2446,0.737587283650495,0.8087378334960784,0.2461562194294734,"['ANLN', 'CDKN1B', 'H2AFZ', 'RPA3', 'POLE2']",0.99998491027236,0,0,5
309,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.7396918503661819,0.8163265306122449,0.24614007994630954,"['SHC3', 'PDGFC', 'GAB1', 'BAX', 'IGF1', 'HRAS']",0.99998491027236,0,0,6
310,IL-6 signaling pathway WP364,0.7404713997264263,0.7795454545454545,0.23422867328883198,"['PRKCD', 'GAB1', 'VIP']",0.99998491027236,0,0,3
311,Metabolic reprogramming in colon cancer WP4290,0.7404713997264263,0.7795454545454545,0.23422867328883198,"['LDHA', 'PKM', 'PGAM1']",0.99998491027236,0,0,3
312,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.7515880525045596,0.7457553488035333,0.21296304882235287,"['CDKN1B', 'HRAS']",0.99998491027236,0,0,2
313,Rett syndrome causing genes WP4312,0.7523542394280687,0.7793615892031238,0.22176578372791125,"['SATB2', 'IMPDH2', 'HAP1', 'GABRD']",0.99998491027236,0,0,4
314,PPAR signaling pathway WP3942,0.7573695571602425,0.7565441176470589,0.2102466048437884,"['FABP3', 'SCD', 'SLC27A6']",0.99998491027236,0,0,3
315,Apoptosis Modulation by HSP70 WP384,0.7615957337759933,0.7148502495840267,0.19468188604593192,['CYCS'],0.99998491027236,0,0,1
316,Globo Sphingolipid Metabolism WP1424,0.7615957337759933,0.7148502495840267,0.19468188604593192,['B3GALNT1'],0.99998491027236,0,0,1
317,Heart Development WP1591,0.7615957337759933,0.7148502495840267,0.19468188604593192,['VEGFB'],0.99998491027236,0,0,1
318,MAPK pathway in congenital thyroid cancer WP4928,0.7615957337759933,0.7148502495840267,0.19468188604593192,['JUN'],0.99998491027236,0,0,1
319,PI3K-Akt signaling pathway WP4172,0.7695658847585931,0.8509807402147865,0.2228962867953838,"['CDKN1B', 'ANGPT2', 'F2R', 'ITGA1', 'FN1', 'VEGFB', 'IGF1', 'FGF1', 'RELN', 'FGF9', 'IL7', 'GNG4', 'DDIT4', 'PDGFC', 'KIT', 'COL6A6', 'HRAS']",0.99998491027236,0,0,17
320,PDGFR-beta pathway WP3972,0.7709274081383982,0.7146128226477935,0.18591443137335448,"['JUN', 'HRAS']",0.99998491027236,0,0,2
321,Metapathway biotransformation Phase I and II WP702,0.776046569620724,0.7789929368876737,0.19750801004825314,"['GPX4', 'GSS', 'CYP51A1', 'KCNAB1', 'SULT4A1', 'FMO5']",0.99998491027236,0,0,6
322,MECP2 and Associated Rett Syndrome WP3584,0.7770203598348241,0.7651890054853328,0.19304855920855385,"['SST', 'GAD1', 'OPRK1', 'IGF1', 'FKBP5']",0.99998491027236,0,0,5
323,Integrated breast cancer pathway WP1984,0.7827060273960003,0.8079362317923737,0.19794283963127093,"['JUN', 'GADD45A', 'ODC1', 'BAX', 'PHB', 'HMGCR', 'FAU', 'JAKMIP1', 'BACH1', 'RPP38']",0.99998491027236,0,0,10
324,Transcription co-factors SKI and SKIL protein partners WP4533,0.7865065840135986,0.6597977729425317,0.1584531965818412,['SATB2'],0.99998491027236,0,0,1
325,Urea cycle and associated pathways WP4595,0.7865065840135986,0.6597977729425317,0.1584531965818412,['GOT1'],0.99998491027236,0,0,1
326,miRNA regulation of prostate cancer signaling pathways WP3981,0.7889398455572377,0.685961698584513,0.16261764892394764,"['CDKN1B', 'TCF7']",0.99998491027236,0,0,2
327,Neural Crest Cell Migration during Development WP4564,0.7889398455572377,0.685961698584513,0.16261764892394764,"['JUN', 'EPHB3']",0.99998491027236,0,0,2
328,Prion disease pathway WP3995,0.7889398455572377,0.685961698584513,0.16261764892394764,"['HSPA5', 'RFX5']",0.99998491027236,0,0,2
329,AMP-activated protein kinase (AMPK) signaling WP1403,0.7935922280716505,0.7294021613756144,0.16862721527956726,"['LIPE', 'STRADB', 'LEPR', 'HMGCR']",0.99998491027236,0,0,4
330,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.8027652759745414,0.695,0.15268657706444475,"['MAP1LC3A', 'GTPBP2', 'FTL']",0.99998491027236,0,0,3
331,ATM Signaling Pathway WP2516,0.8056914202232194,0.6595145071414846,0.1424910527495023,"['JUN', 'GADD45A']",0.99998491027236,0,0,2
332,DNA Replication WP466,0.8056914202232194,0.6595145071414846,0.1424910527495023,"['RPA3', 'POLE2']",0.99998491027236,0,0,2
333,Tumor suppressor activity of SMARCB1 WP4204,0.8056914202232194,0.6595145071414846,0.1424910527495023,"['H3F3B', 'GLI3']",0.99998491027236,0,0,2
334,Constitutive Androstane Receptor Pathway WP2875,0.8088164176525052,0.6126099358212503,0.12998560557722158,['ABCB1'],0.99998491027236,0,0,1
335,Gastric Cancer Network 1 WP2361,0.8088164176525052,0.6126099358212503,0.12998560557722158,['KIF15'],0.99998491027236,0,0,1
336,Hematopoietic Stem Cell Differentiation WP2849,0.8088164176525052,0.6126099358212503,0.12998560557722158,['RUNX1'],0.99998491027236,0,0,1
337,Toll-like Receptor Signaling related to MyD88 WP3858,0.8088164176525052,0.6126099358212503,0.12998560557722158,['TICAM2'],0.99998491027236,0,0,1
338,TGF-beta Signaling Pathway WP366,0.8156164385541624,0.7611715481171548,0.1551351993349411,"['TGFBR3', 'JUN', 'TGFB1', 'PARD6A', 'SUMO1', 'FN1', 'STRAP', 'NEDD9']",0.99998491027236,0,0,8
339,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.8162217242753901,0.6766447368421052,0.13740573246171162,"['EIF4A2', 'RPS6KA5', 'PRKCD']",0.99998491027236,0,0,3
340,CAMKK2  Pathway WP4874,0.8212488635945159,0.6350263669164585,0.12505516642682174,"['FIS1', 'MAP1LC3A']",0.99998491027236,0,0,2
341,Hedgehog Signaling Pathway WP4249,0.8212488635945159,0.6350263669164585,0.12505516642682174,"['HHIP', 'GLI3']",0.99998491027236,0,0,2
342,Hepatitis C and Hepatocellular Carcinoma WP3646,0.8212488635945159,0.6350263669164585,0.12505516642682174,"['JUN', 'TGFB1']",0.99998491027236,0,0,2
343,IL-5 signaling pathway WP127,0.8212488635945159,0.6350263669164585,0.12505516642682174,"['SPRED1', 'JUN']",0.99998491027236,0,0,2
344,Type 2 papillary renal cell carcinoma WP4241,0.8212488635945159,0.6350263669164585,0.12505516642682174,"['TGFB1', 'ELOB']",0.99998491027236,0,0,2
345,Pathways in clear cell renal cell carcinoma WP4018,0.8223005938368059,0.71389816360601,0.13967365088007613,"['LDHA', 'PKM', 'TGFB1', 'ALDOC', 'PFKM']",0.99998491027236,0,0,5
346,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.8287966118861017,0.5717138103161398,0.10735670256279659,['FGF1'],0.99998491027236,0,0,1
347,Immune response to tuberculosis WP4197,0.8287966118861017,0.5717138103161398,0.10735670256279659,['IFIT3'],0.99998491027236,0,0,1
348,Monoamine Transport WP727,0.8287966118861017,0.5717138103161398,0.10735670256279659,['SLC6A1'],0.99998491027236,0,0,1
349,MET in type 1 papillary renal cell carcinoma WP4205,0.8291221920649545,0.6854378648874062,0.12844265088086057,"['JUN', 'RPL11', 'GAB1', 'HRAS']",0.99998491027236,0,0,4
350,B Cell Receptor Signaling Pathway WP23,0.8323823338833023,0.7021264949779688,0.12881451947377703,"['JUN', 'CD81', 'PRKCD', 'GAB1', 'HRAS']",0.99998491027236,0,0,5
351,Amyotrophic lateral sclerosis (ALS) WP2447,0.8356787233168923,0.6122873795646485,0.1099123455170542,"['TOMM40', 'BAX']",0.99998491027236,0,0,2
352,MAPK Cascade WP422,0.8356787233168923,0.6122873795646485,0.1099123455170542,"['JUN', 'HRAS']",0.99998491027236,0,0,2
353,Neural Crest Cell Migration in Cancer WP4565,0.8356787233168923,0.6122873795646485,0.1099123455170542,"['JUN', 'EPHB3']",0.99998491027236,0,0,2
354,7q11.23 copy number variation syndrome WP4932,0.8370702222559288,0.7136591478696742,0.12692236288415526,"['ATP5MC2', 'EIF4H', 'ATP5MC3', 'UBE2L6', 'ATP5F1E', 'ATP5MC1']",0.99998491027236,0,0,6
355,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.8397760746584797,0.6719324927635775,0.1173328522025042,"['PSMD8', 'PSMC5', 'HSPA5', 'UBE2L6']",0.99998491027236,0,0,4
356,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.8397760746584797,0.6719324927635775,0.1173328522025042,"['JUN', 'CDKN1B', 'APEX1', 'HRAS']",0.99998491027236,0,0,4
357,DNA IR-double strand breaks and cellular response via ATM WP3959,0.8408020574582091,0.6426875,0.11144137778046141,"['DCLRE1C', 'KAT5', 'BAX']",0.99998491027236,0,0,3
358,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.8466902507314779,0.5359297004991681,0.08918960984965923,['H3F3B'],0.99998491027236,0,0,1
359,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.8466902507314779,0.5359297004991681,0.08918960984965923,['HRAS'],0.99998491027236,0,0,1
360,Mitochondrial Gene Expression WP391,0.8466902507314779,0.5359297004991681,0.08918960984965923,['PPRC1'],0.99998491027236,0,0,1
361,NAD+ biosynthetic pathways WP3645,0.8466902507314779,0.5359297004991681,0.08918960984965923,['ACMSD'],0.99998491027236,0,0,1
362,Oxidative Stress WP408,0.8466902507314779,0.5359297004991681,0.08918960984965923,['TXN2'],0.99998491027236,0,0,1
363,Purine metabolism and related disorders WP4224,0.8466902507314779,0.5359297004991681,0.08918960984965923,['PRPS1'],0.99998491027236,0,0,1
364,Hepatitis B infection WP4666,0.8480924743311345,0.7284963945517671,0.12003114497571199,"['JUN', 'TICAM2', 'TGFB1', 'ATP6AP1', 'CYCS', 'PTK2B', 'BAX', 'HRAS']",0.99998491027236,0,0,8
365,Netrin-UNC5B signaling pathway WP4747,0.8490466748991197,0.5911165982371013,0.09673098091986719,"['JUN', 'PTK2B']",0.99998491027236,0,0,2
366,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.8490466748991197,0.5911165982371013,0.09673098091986719,"['TGFB1', 'IFIT2']",0.99998491027236,0,0,2
367,Vitamin D-sensitive calcium signaling in depression WP4698,0.8490466748991197,0.5911165982371013,0.09673098091986719,"['GPX4', 'PVALB']",0.99998491027236,0,0,2
368,Head and Neck Squamous Cell Carcinoma WP4674,0.8498667657201654,0.6589465580291268,0.10719458467953383,"['DDIT4', 'GAB1', 'FAT1', 'HRAS']",0.99998491027236,0,0,4
369,Wnt signaling WP428,0.8511445124572794,0.6797042690197949,0.10955021401477086,"['SFRP4', 'SFRP1', 'JUN', 'TCF7', 'CXXC4']",0.99998491027236,0,0,5
370,Cardiac Hypertrophic Response WP2795,0.8519894791682326,0.6269512195121951,0.10042573637849361,"['TGFB1', 'PRKD1', 'IGF1']",0.99998491027236,0,0,3
371,NO/cGMP/PKG mediated Neuroprotection WP4008,0.8614169792885863,0.5713572023313905,0.08523312213575121,"['PDE3A', 'CYCS']",0.99998491027236,0,0,2
372,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.8614169792885863,0.5713572023313905,0.08523312213575121,"['JUN', 'BAX']",0.99998491027236,0,0,2
373,AGE/RAGE pathway WP2324,0.8624847430650822,0.6119642857142857,0.09053266199943424,"['JUN', 'PRKCD', 'CYCS']",0.99998491027236,0,0,3
374,16p11.2 distal deletion syndrome WP4950,0.8627150728637036,0.5043554859547813,0.07447857876090148,['CD81'],0.99998491027236,0,0,1
375,1q21.1 copy number variation syndrome WP4905,0.8627150728637036,0.5043554859547813,0.07447857876090148,['FMO5'],0.99998491027236,0,0,1
376,Fluoropyrimidine Activity WP1601,0.8627150728637036,0.5043554859547813,0.07447857876090148,['DPYD'],0.99998491027236,0,0,1
377,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.8627150728637036,0.5043554859547813,0.07447857876090148,['LDHA'],0.99998491027236,0,0,1
378,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.8627150728637036,0.5043554859547813,0.07447857876090148,['MAP1LC3A'],0.99998491027236,0,0,1
379,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.8627150728637036,0.5043554859547813,0.07447857876090148,['GOT1'],0.99998491027236,0,0,1
380,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.8627150728637036,0.5043554859547813,0.07447857876090148,['HRAS'],0.99998491027236,0,0,1
381,Vitamin D in inflammatory diseases WP4482,0.8627150728637036,0.5043554859547813,0.07447857876090148,['DUSP1'],0.99998491027236,0,0,1
382,Pancreatic adenocarcinoma pathway WP4263,0.8681282858241713,0.6586618723513549,0.0931451827734083,"['TGFB1', 'GADD45A', 'PRKCD', 'BAX', 'GADD45G']",0.99998491027236,0,0,5
383,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.8723201643498746,0.5976744186046512,0.08164158536674072,"['CDKN1B', 'TGFB1', 'FAT1']",0.99998491027236,0,0,3
384,Prader-Willi and Angelman Syndrome WP3998,0.8728520627897612,0.5528726061615321,0.07518470116540463,"['NDN', 'GABRD']",0.99998491027236,0,0,2
385,Fatty Acid Biosynthesis WP357,0.8770661120727179,0.4762895174708819,0.06247627967712186,['SCD'],0.99998491027236,0,0,1
386,Gastric Cancer Network 2 WP2363,0.8770661120727179,0.4762895174708819,0.06247627967712186,['FANCI'],0.99998491027236,0,0,1
387,Glycerolipids and Glycerophospholipids WP4722,0.8770661120727179,0.4762895174708819,0.06247627967712186,['CDIPT'],0.99998491027236,0,0,1
388,PKC-gamma calcium signaling pathway in ataxia WP4760,0.8770661120727179,0.4762895174708819,0.06247627967712186,['TRPC3'],0.99998491027236,0,0,1
389,Glycogen Synthesis and Degradation WP500,0.8834121997542501,0.5355432972522898,0.06638775186266926,"['PHKG1', 'GYG1']",0.99998491027236,0,0,2
390,22q11.2 copy number variation syndrome WP4657,0.883446811453721,0.6388757381705829,0.07917215908175347,"['RANBP1', 'MRPL40', 'RELN', 'THAP7', 'RCC1']",0.99998491027236,0,0,5
391,ESC Pluripotency Pathways WP3931,0.883446811453721,0.6388757381705829,0.07917215908175347,"['JUN', 'FGF9', 'GAB1', 'FGF1', 'HRAS']",0.99998491027236,0,0,5
392,16p11.2 proximal deletion syndrome WP4949,0.8849989692500165,0.6116406529250566,0.07472340378199988,"['ASPHD1', 'SEZ6L2', 'CCT7', 'CDIPT']",0.99998491027236,0,0,4
393,Cell migration and invasion through p75NTR WP4561,0.8899180633674689,0.4511778614589719,0.052619016990787026,['JUN'],0.99998491027236,0,0,1
394,Estrogen signaling pathway WP712,0.8899180633674689,0.4511778614589719,0.052619016990787026,['JUN'],0.99998491027236,0,0,1
395,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.8899180633674689,0.4511778614589719,0.052619016990787026,['FGF9'],0.99998491027236,0,0,1
396,Physiological and pathological hypertrophy of the heart WP1528,0.8899180633674689,0.4511778614589719,0.052619016990787026,['JUN'],0.99998491027236,0,0,1
397,Sphingolipid Metabolism (general overview) WP4725,0.8899180633674689,0.4511778614589719,0.052619016990787026,['CERS4'],0.99998491027236,0,0,1
398,3q29 copy number variation syndrome WP4906,0.8901393730938931,0.571,0.06645139806413654,"['JUN', 'TGFB1', 'NCBP2']",0.99998491027236,0,0,3
399,Pathways affected in adenoid cystic carcinoma WP3651,0.8901393730938931,0.571,0.06645139806413654,"['MYCBP', 'HRAS', 'FOXP2']",0.99998491027236,0,0,3
400,Interleukin-11 Signaling Pathway WP2332,0.8931552818080719,0.5192642494890621,0.05867417321754069,"['TGFB1', 'HRAS']",0.99998491027236,0,0,2
401,PDGF Pathway WP2526,0.8931552818080719,0.5192642494890621,0.05867417321754069,"['JUN', 'HRAS']",0.99998491027236,0,0,2
402,DNA IR-damage and cellular response via ATR WP4016,0.8997123277948273,0.5904345575335769,0.062397243624258206,"['FANCI', 'SEM1', 'POLN', 'ABRAXAS1']",0.99998491027236,0,0,4
403,Cannabinoid receptor signaling WP3869,0.90142740216438,0.4285773710482529,0.04447594652505229,['PRKAR1A'],0.99998491027236,0,0,1
404,Nanoparticle triggered autophagic cell death WP2509,0.90142740216438,0.4285773710482529,0.04447594652505229,['MAP1LC3A'],0.99998491027236,0,0,1
405,Sphingolipid Metabolism (integrated pathway) WP4726,0.90142740216438,0.4285773710482529,0.04447594652505229,['CERS4'],0.99998491027236,0,0,1
406,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9063762660312261,0.6750198360222164,0.06635495917268038,"['LINGO1', 'JUN', 'RAB3A', 'RPS6KA5', 'SHC3', 'PRKCD', 'PTK2B', 'HRAS', 'CDK5R1']",0.99998491027236,0,0,9
407,Cell cycle WP179,0.9095538272253747,0.6026476051635354,0.05713165555632053,"['TGFB1', 'CDKN1B', 'GADD45A', 'ANAPC11', 'GADD45G']",0.99998491027236,0,0,5
408,ErbB signaling pathway WP673,0.9095538272253747,0.6026476051635354,0.05713165555632053,"['JUN', 'CDKN1B', 'SHC3', 'GAB1', 'HRAS']",0.99998491027236,0,0,5
409,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9127042221241373,0.53515625,0.0488829986300892,"['ITGA1', 'TCF7', 'ACTG1']",0.99998491027236,0,0,3
410,Hippo-Merlin Signaling Dysregulation WP4541,0.9152216499823131,0.5942195325542571,0.0526413157288355,"['PRKAR1A', 'ITGA1', 'KIT', 'HRAS', 'CDH18']",0.99998491027236,0,0,5
411,RANKL/RANK signaling pathway WP2018,0.9180224267595611,0.4758534554537885,0.04070139185016111,"['JUN', 'PAPSS2']",0.99998491027236,0,0,2
412,Leptin signaling pathway WP2034,0.9186700036236967,0.561232721256785,0.047608419406228966,"['CFL2', 'LEPR', 'BAX', 'HRAS']",0.99998491027236,0,0,4
413,IL17 signaling pathway WP2112,0.9209642408122074,0.3895401603388292,0.032072426813677966,['TRAF3IP2'],0.99998491027236,0,0,1
414,Histone Modifications WP2369,0.9250241373024997,0.462947543713572,0.036080023955512464,"['SET', 'H3F3B']",0.99998491027236,0,0,2
415,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.9250241373024997,0.462947543713572,0.036080023955512464,"['TGFB1', 'TCF7']",0.99998491027236,0,0,2
416,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.9292297146010633,0.37256746003038416,0.02734619073350203,['JUN'],0.99998491027236,0,0,1
417,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.9292297146010633,0.37256746003038416,0.02734619073350203,['CAMK1G'],0.99998491027236,0,0,1
418,The influence of laminopathies on Wnt signaling WP4844,0.9292297146010633,0.37256746003038416,0.02734619073350203,['TCF7'],0.99998491027236,0,0,1
419,Male infertility WP4673,0.9294587745171421,0.5433099011080662,0.03974465418485074,"['ABCB1', 'PEX10', 'TEX15', 'ETV5']",0.99998491027236,0,0,4
420,TNF-alpha signaling pathway WP231,0.9294587745171421,0.5433099011080662,0.03974465418485074,"['JUN', 'RFK', 'BAX', 'HRAS']",0.99998491027236,0,0,4
421,Ectoderm Differentiation WP2858,0.9315451156037157,0.6106665074056379,0.04330276314403395,"['PPFIBP2', 'MAFB', 'SPRY2', 'NR2F2', 'JAKMIP1', 'PTPN13', 'GLI3']",0.99998491027236,0,0,7
422,Glycerophospholipid Biosynthetic Pathway WP2533,0.9366314126199692,0.3570091514143095,0.02337176253908766,['CDIPT'],0.99998491027236,0,0,1
423,Melatonin metabolism and effects WP3298,0.9366314126199692,0.3570091514143095,0.02337176253908766,['PER2'],0.99998491027236,0,0,1
424,Nuclear receptors WP170,0.9366314126199692,0.3570091514143095,0.02337176253908766,['NR2F2'],0.99998491027236,0,0,1
425,MAPK Signaling Pathway WP382,0.9395296249777726,0.6725439266615737,0.04195055149196867,"['DUSP4', 'JUN', 'TGFB1', 'GADD45A', 'DUSP1', 'PRKCD', 'HSPB1', 'FGF1', 'DUSP7', 'RPS6KA5', 'FGF9', 'DDIT3', 'HRAS']",0.99998491027236,0,0,13
426,Fatty acid beta-oxidation WP143,0.9432595354856662,0.3426955074875208,0.020018150607353225,['LIPE'],0.99998491027236,0,0,1
427,EGF/EGFR signaling pathway WP437,0.948098520611714,0.6149547738693467,0.03277515690943452,"['NDUFA13', 'JUN', 'RPS6KA5', 'PRKCD', 'GAB1', 'PTK2B', 'SPRY2', 'HRAS', 'ARF6']",0.99998491027236,0,0,9
428,Chemokine signaling pathway WP3929,0.950966948190823,0.5574261741309796,0.028025142630587183,"['SHC3', 'GNG4', 'PRKCD', 'PTK2B', 'CXCL14', 'HRAS']",0.99998491027236,0,0,6
429,mRNA Processing WP411,0.9513447465973747,0.5942441331635437,0.029640167963981008,"['SF3B5', 'LSM7', 'SF3A1', 'SNRPD1', 'NCBP2', 'SNRPE', 'SNU13', 'SRSF9']",0.99998491027236,0,0,8
430,Kit receptor signaling pathway WP304,0.952328162232121,0.4076364933983585,0.01991124721131473,"['KIT', 'HRAS']",0.99998491027236,0,0,2
431,Alzheimer's disease WP2059,0.9537812787290512,0.45834821428571426,0.021689450654755263,"['ATP5MD', 'CYCS', 'CDK5R1']",0.99998491027236,0,0,3
432,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.9545097778193128,0.317249029395452,0.014770287407714982,['SUPT4H1'],0.99998491027236,0,0,1
433,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.9545097778193128,0.317249029395452,0.014770287407714982,['JUN'],0.99998491027236,0,0,1
434,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9567654213328141,0.5212447575227004,0.02303747349557605,"['TGFB1', 'ID2', 'FN1', 'STRAP', 'HRAS']",0.99998491027236,0,0,5
435,Phosphoinositides metabolism WP4971,0.9592690605270542,0.30588899453292134,0.012719990007032562,['PIP4P1'],0.99998491027236,0,0,1
436,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9622680394604625,0.5339912280701754,0.020538498680098993,"['DLX2', 'JUN', 'PRKAR1A', 'SST', 'ATP1A3', 'ASCL1']",0.99998491027236,0,0,6
437,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9667297342592123,0.427625,0.014469252690970645,"['TGFB1', 'IGF1', 'MYLK']",0.99998491027236,0,0,3
438,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.9673468631332984,0.28544093178036606,0.009476110185791645,['ACTG1'],0.99998491027236,0,0,1
439,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.9707639223924464,0.2762063227953411,0.008195585331689315,['GABRD'],0.99998491027236,0,0,1
440,Toll-like Receptor Signaling Pathway WP75,0.9726481102276251,0.356473771856786,0.0098860574032392,"['JUN', 'TICAM2']",0.99998491027236,0,0,2
441,G13 Signaling Pathway WP524,0.9738236349399,0.2675488768718802,0.007096751267370965,['CFL2'],0.99998491027236,0,0,1
442,Corticotropin-releasing hormone signaling pathway WP2355,0.9741056367440133,0.40714285714285714,0.0106816064461445,"['TGFB1', 'PRKCD', 'CRH']",0.99998491027236,0,0,3
443,Endoderm differentiation WP2853,0.9788560412759622,0.46413406401974305,0.009918867042704435,"['DUSP4', 'SFRP1', 'TGFB1', 'TCF7', 'PBX3']",0.99998491027236,0,0,5
444,Pathogenic Escherichia coli infection WP2272,0.9812130248768065,0.24454480627525552,0.004637961537079041,['ACTG1'],0.99998491027236,0,0,1
445,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.9812130248768065,0.24454480627525552,0.004637961537079041,['JUN'],0.99998491027236,0,0,1
446,Regulation of toll-like receptor signaling pathway WP1449,0.9815535871587987,0.3826865671641791,0.007125114734818978,"['JUN', 'TICAM2', 'PELI3']",0.99998491027236,0,0,3
447,Common Pathways Underlying Drug Addiction WP2636,0.9831797717800285,0.23772878535773712,0.004032663469132553,['ACTG1'],0.99998491027236,0,0,1
448,Thermogenesis WP4321,0.9832853268946243,0.4166480196912061,0.007022993860742273,"['LIPE', 'ADCY10', 'HRAS', 'ACTG1']",0.99998491027236,0,0,4
449,Splicing factor NOVA regulated synaptic proteins WP4148,0.9849407512112364,0.23128119800332778,0.0035094124852830455,['EPB41'],0.99998491027236,0,0,1
450,Prolactin Signaling Pathway WP2037,0.9858878683522344,0.3108924381197487,0.004418606849215458,"['JUN', 'HRAS']",0.99998491027236,0,0,2
451,IL-4 signaling pathway WP395,0.9865174749338119,0.2251729573517821,0.0030565516751080955,['HRH1'],0.99998491027236,0,0,1
452,Integrin-mediated Cell Adhesion WP185,0.9869272984516332,0.3609859154929577,0.0047501780610021745,"['SHC3', 'ITGA1', 'HRAS']",0.99998491027236,0,0,3
453,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.9891932006990224,0.21387271214642262,0.002323858954190212,['RPS6KA5'],0.99998491027236,0,0,1
454,Ras signaling WP4223,0.9894542017324061,0.4698864983014247,0.0049816423313425486,"['HTR7', 'SHC3', 'GNG4', 'KIT', 'GAB1', 'HRAS', 'ARF6']",0.99998491027236,0,0,7
455,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9900153417152432,0.418221545713444,0.004196785999481292,"['SLCO1C1', 'RPS6KA5', 'SHC3', 'SCD', 'HRAS']",0.99998491027236,0,0,5
456,Energy Metabolism WP1541,0.9903249040687081,0.20863601314881702,0.0020284018329121047,['PPRC1'],0.99998491027236,0,0,1
457,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.9903841414436595,0.28970208442117446,0.0027992143653639,"['SLCO1C1', 'HRAS']",0.99998491027236,0,0,2
458,Interferon type I signaling pathways WP585,0.992245335071413,0.1988933173393182,0.0015483623375014176,['RPS6KA5'],0.99998491027236,0,0,1
459,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.992245335071413,0.1988933173393182,0.0015483623375014176,['HRAS'],0.99998491027236,0,0,1
460,Fragile X Syndrome  WP4549,0.9937263165607428,0.3947551474680022,0.0024843700811601715,"['PRKAR1A', 'GAD1', 'GAB1', 'SLC6A1', 'GABRD']",0.99998491027236,0,0,5
461,Ciliopathies WP4803,0.9944099691226224,0.43840374778674013,0.0024575658388904104,"['MAK', 'NME9', 'HYDIN', 'CCDC65', 'CCNQ', 'CCDC28B', 'GLI3']",0.99998491027236,0,0,7
462,IL-1 signaling pathway WP195,0.9950186158145542,0.1818954225227458,0.0009083552975515898,['JUN'],0.99998491027236,0,0,1
463,Neural Crest Differentiation WP2064,0.9950186158145542,0.1818954225227458,0.0009083552975515898,['ASCL1'],0.99998491027236,0,0,1
464,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9960076025234492,0.1744371625522089,0.000697816396543837,['F2R'],0.99998491027236,0,0,1
465,Mesodermal commitment pathway WP2857,0.9971158698928995,0.29076704545454546,0.0008398216503932316,"['PRKAR1A', 'PBX3', 'RPL38']",0.99998491027236,0,0,3
466,Joubert Syndrome WP4656,0.9993196719577834,0.13129399718418022,8.93533863138763e-05,['KAT5'],0.99998491027236,0,0,1
467,Genes related to primary cilium development (based on CRISPR) WP4536,0.9999665544868702,0.09151414309484193,3.060788659548231e-06,['TULP3'],0.99998491027236,0,0,1
468,Ciliary landscape WP4352,0.99998491027236,0.23255333981544332,3.509193036031049e-06,"['PSMD8', 'DOCK5', 'COPS7A', 'MYL6B', 'LSM4']",0.99998491027236,0,0,5
